OrbiMed’s Nuvectra Corporation Common Stock NVTR Stock Holding History

OrbiMed’s Portfolio NVTR Stock Details NVTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-350,000	Closed	-$1.17M	–	147
2019 Q2	$1.17M	Hold	350,000	–	–	0.02%	125
2019 Q1	$3.85M	Hold	350,000	–	–	0.06%	113
2018 Q4	$5.72M	Hold	350,000	–	–	0.11%	98
2018 Q3	$7.69M	Buy	+350,000	New	+$6.73M	0.09%	119

Other funds holding NVTR

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

PCM

Penn Capital Management Philadelphia, Pennsylvania $1.29B AUM 53.44% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return

OrbiMed's NVTR Position: Q3 2019 in Review

OrbiMed sold out of Nuvectra Corporation Common Stock (NVTR) in Q3 2019, closing a stake of 350,000 shares — an estimated $1.17M sold.

OrbiMed first reported a position in NVTR in Q3 2018 and held it in 4 quarters. The position peaked at $7.69M in Q3 2018. 76 funds tracked by Wall St. Rank hold NVTR as of Q3 2019.

OrbiMed reported no remaining Nuvectra Corporation Common Stock position as of Q3 2019 after selling out during the quarter.
OrbiMed sold 350,000 Nuvectra Corporation Common Stock shares in Q3 2019, an estimated $1.17M.
OrbiMed first reported a position in Nuvectra Corporation Common Stock in Q3 2018 and held it in 4 quarters.
OrbiMed's Nuvectra Corporation Common Stock position peaked at $7.69M in Q3 2018.
76 funds tracked by Wall St. Rank held Nuvectra Corporation Common Stock as of Q3 2019.

Based on OrbiMed's 13F filing for Q3 2019, filed 14 Nov 2019.